Error loading player: No playable sources found

Player size: small large

Short Talk: Therapeutic Drugs Promote Differentiation of AML Blasts to a Mixed M1/M2 and Migratory Phenotype Resistant to Treatment Facilitated by the Bone Marrow Microenvironment.

Date

September 23, 2020

This product is not available for individual purchase, but it is available as part of the following products:

Thumbnail for eSymposia | Myeloid Cells and Innate Immunity in Solid Tumors - Regular Rate

eSymposia | Myeloid Cells and Innate Immunity in Solid Tumors - Regular Rate

Speaker

Yolanda Calle, PhD

University of Roehampton

Tracks

Targeting Myeloid Cells in Cancer Therapy I

Related Products

Thumbnail for Short Talk: Polarization of TAMs by Iron Nanoparticles as an Adjuvant Lung Cancer Therapy

Short Talk: Polarization of TAMs by Iron Nanoparticles as an Adjuvant Lung Cancer Therapy

Thumbnail for MTL - CEBPA - Next Generation Immunotherapy Targeting Myeloid Cell Differentiation

MTL - CEBPA - Next Generation Immunotherapy Targeting Myeloid Cell Differentiation

Thumbnail for CD47 Targeting in Cancer Therapy

CD47 Targeting in Cancer Therapy

Thumbnail for Mechanisms Governing Accumulation of Macrophages in Cancer

Mechanisms Governing Accumulation of Macrophages in Cancer

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.